Indication
Human Papillomavirus Infection
Aliases
Papillomavirus Infection
32 clinical trials
28 products
8 drugs
Clinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Suppositories for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)Status: Active (not recruiting), Estimated PCD: 2024-02-28
Product
ArtesunateClinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Ointment for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)Status: Recruiting, Estimated PCD: 2025-12-31
Product
PlaceboClinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2/3)Status: Recruiting, Estimated PCD: 2025-07-31
Product
ChAdOx1-HPVProduct
MVA-HPVClinical trial
A Phase 1b/2, Randomised, Placebo-controlled, Dose-ranging Study to Evaluate Safety, Tolerability and Immunogenicity of a Chimpanzee Adenovirus (ChAdOx1)-Vectored Multigenotype High Risk Human Papillomavirus (hrHPV) Vaccine and Modified Vaccinia Ankara (MVA)-Vectored Multigenotype hrHPV Vaccine in Women With Low-grade HPV-related Cervical LesionsStatus: Completed, Estimated PCD: 2024-01-16
Clinical trial
A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL)Status: Recruiting, Estimated PCD: 2024-12-01
Product
Placebo vaginal insertClinical trial
Randomised, Double-blind, Placebo-controlled Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV-16 Infected Women With Normal Cytology, CIN1 or CIN2Status: Completed, Estimated PCD: 2023-03-16
Clinical trial
Randomised, Double-blind, Placebo-controlled Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women With NILM, ASC-US, LSIL or Low-grade CINStatus: Recruiting, Estimated PCD: 2024-09-01
Product
FluBHPVE6E7Clinical trial
A Phase II Trial in Healthy Chinese Women Ages 20-45 to Evaluate the Immunogenicity and Safety Profile of Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)Status: Completed, Estimated PCD: 2020-12-11
Product
9vHPV Vaccine + BCG VaccineClinical trial
Conducting an Early Phase Clinical Trial to Assess for HPV Antigen Presentation Therapeutic Biological Product Mix Activity That Suggests the Potential for Clinical Benefits of HPV Patients.Status: Active (not recruiting), Estimated PCD: 2024-02-28
Clinical trial
A Phase III, Randomized, Double-blind Study to Assess the Consistency of the Immunogenicity of Three Consecutive Production Lots of Bivalent HPV Vaccine in Healthy Female Subjects Aged 9 - 30 Years and to Demonstrate Non-inferiority of the Candidate HPV Vaccine Manufactured at Commercial Scale Compared With a Pilot ScaleStatus: Completed, Estimated PCD: 2022-04-27
Clinical trial
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx CancerStatus: Active (not recruiting), Estimated PCD: 2020-11-30
Product
cisplatinDrug
carboplatinClinical trial
ANCHOR Study: Anal Cancer/HSIL Outcomes Research StudyStatus: Active (not recruiting), Estimated PCD: 2021-08-06
Drug
imiquimodDrug
fluorouracilClinical trial
A Multi-site, Open-label Non-inferiority Trial to Assess Immunogenicity of Two Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults (9-26 Years) Living With HIV vs Three Doses of Nonavalent HPV Vaccine Among HIV Uninfected Young Women (15-26 Years) in EswatiniStatus: Active (not recruiting), Estimated PCD: 2023-09-30
Product
Gardasil 9Clinical trial
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in TanzaniaStatus: Active (not recruiting), Estimated PCD: 2025-11-01
Product
GardasilClinical trial
The Effects of Probiotic Against Reducing Abundance of Human Papilloma Virus (HPV) in WomenStatus: Withdrawn, Estimated PCD: 2023-11-28
Product
probioticClinical trial
Evaluation of HPV Vaccine Immunity in High-risk Women: a Pilot StudyStatus: Completed, Estimated PCD: 2023-04-19
Clinical trial
An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV TrialStatus: Active (not recruiting), Estimated PCD: 2019-03-31
Drug
AbraxaneDrug
paclitaxelClinical trial
Evaluation of Efficacy of AHCC®for the Clearance of High Risk-HPV Infections in Chinese Female: A Multi-centre, Randomised, Double Blind and Placebo-controlled StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Product
AHCC®capsulesProduct
AHCCClinical trial
Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.Status: Active (not recruiting), Estimated PCD: 2024-12-31
Product
HPV vaccineClinical trial
Immunogenicity of 9-valent HPV Vaccine in Immunocompromised Children and AdolescentsStatus: Recruiting, Estimated PCD: 2024-09-01
Product
9-valent HPV vaccineClinical trial
Interferon Alpha Therapy for Cervical CIN I and HPV InfectionStatus: Recruiting, Estimated PCD: 2024-03-15
Product
Gel InterferonClinical trial
Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of AgeStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
Double-Blind Randomized Phase II Clinical Trial Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+Status: Not yet recruiting, Estimated PCD: 2026-01-01
Drug
pBI-11Drug
hydroxyureaClinical trial
A Longitudinal Cohort Study to Assess Effectiveness and B-memory Response to the Quadrivalent HPV Vaccine 9 Years Post-vaccination Among HIV-Infected Boys and Girls Ages 9-14 Years in KenyaStatus: Completed, Estimated PCD: 2023-10-31
Clinical trial
Immunogenicity of Fractional Dose of the HPV VaccinesStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Therapeutic Effect of Topical Estrogen and Human Interferon Alpha 2b Vaginal Effervescent Capsules in Perimenopausal and Postmenopausal Women With High-risk HPV InfectionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
Human interferon alpha 2bClinical trial
Interventional Study on Efficacy of Lactobacillus Crispatus M247 in Patients Affected by HPV Low-grade Preneoplastic Cervical Lesions and Evaluation of Vaginal Microbiota Changes Before and After Oral SupplementationStatus: Recruiting, Estimated PCD: 2023-02-02
Product
Lactobacillus Crispatus M247Clinical trial
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIVStatus: Active (not recruiting), Estimated PCD: 2026-04-01
Clinical trial
An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination Regimen Over 6 Months Among Women Aged 16 to 45 Years Old, An Exploratory Immunogenicity StudyStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Randomised, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Tolerability of 15-valent Human Papillomavirus Recombinant Vaccine (Hansenulapolymorpha) in Healthy Chinese People Aged 18-45 YearsStatus: Not yet recruiting, Estimated PCD: 2025-02-05
Drug
VarlilumabClinical trial
Effects of Estrogen-like Chinese Medicine and Vaginal Lactobacillus on HPV Clearance and Vaginal Microbiota Change in Women With Persistent HPV InfectionStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Chinese medicineProduct
LactobacillusClinical trial
A Phase 3 Trial of PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis in Adult PatientsStatus: Recruiting, Estimated PCD: 2027-03-01
Product
PRGN-2012